HUM Stock Summary and Trading Ideas (Humana | NYSE:HUM)

Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Humana trades on the NYSE stock market under the symbol HUM.

As of September 23, 2026, HUM stock price climbed to $374.78 with 739,823 million shares trading.

HUM has a beta of 1.13, meaning it tends to be more sensitive to market movements. HUM has a correlation of 0.07 to the broad based SPY ETF.

HUM has a market cap of $45.00 billion. This is considered a Large Cap stock.

Last quarter Humana reported $41 billion in Revenue and $7.61 earnings per share. This beat revenue expectation by $310 million and exceeded earnings estimates by $.80.

In the last 3 years, HUM traded as high as $530.54 and as low as $163.11.

The top ETF exchange traded funds that HUM belongs to (by Net Assets): VTI, VOO, VO, SPY, VTV.

HUM has outperformed the market in the last year with a return of +46.7%, while the SPY ETF gained +16.3%. In the last 3 month period, HUM beat the market returning +4.1%, while SPY returned +3.4%. However, in the most recent 2 weeks HUM has underperformed the stock market by returning -7.0%, while SPY returned +0.5%.

HUM support price is $363.52 and resistance is $380.48 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HUM shares will trade within this expected range on the day.